Diphenyl substituted Cycloalkanes, compositions containing such compounds and methods of use

Details for Australian Patent Application No. 2004259747 (hide)

Owner Merck & Co., Inc. Merck Frosst Canada Ltd.

Inventors Girard, Yves; Frenette, Richard; Goulet, Mark T.; MacDonald, Dwight; Chang, Linda; Ujjainwalla, Feroze; Chu, Lin; Hutchinson, John H.; Therien, Michel

Agent Spruson & Ferguson

Pub. Number AU-B-2004259747

PCT Pub. Number WO2005/009951

Priority 60/489,693 24.07.03 US

Filing date 20 July 2004

Wipo publication date 3 February 2005

Acceptance publication date 19 February 2009

International Classifications

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

C07D 221/02 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 231/02 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 263/02 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009951 Priority application(s): WO2005/009951

19 February 2009 Application Accepted

  Published as AU-B-2004259747

18 June 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259750-Soluble fragments of the SARS-CoV spike glycoprotein

2004259741-(2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluo rophenyl)-L-phenylalanyl]-2-pyrrolidinec arbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof